| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 Mar 2025 | 25 Mar 2025 |
| Please find the attached Outcome of the Board Meeting held today i.e., 25th March, 2025 Please find the attached outcome of Board Meeting held on 25th March, 2025 in which the Board of Directors of the Company has appointed Ms. Komal Bajaj, as the Internal Auditor of the Company. | ||
| Board Meeting | 1 Feb 2025 | 1 Feb 2025 |
| Please find the attached Outcome of Board Meeting. | ||
| Board Meeting | 27 Jan 2025 | 22 Jan 2025 |
| RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve the agenda items mentioned in the attached Intimation Please find the attached Intimation for change in Directors Outcome of Board Meeting held on 27th January, 2025 Results for the financial year ended 31st December 2024 (As Per Bse Announcement Dated on 27.01.2025) | ||
| Board Meeting | 8 Jan 2025 | 8 Jan 2025 |
| Outcome of Board Meeting for Appointment of Directors Outcome of Board Meeting held for Appointment of Additional Directors | ||
| Board Meeting | 6 Nov 2024 | 28 Oct 2024 |
| Quarterly Results Approval of unaudited standalone Financial results for the quarter and half year ended 30 september 2024 Appointment of Additional Director and Company Secretary Approval of Unaudited Standalone Financial Results for Quarter and Half Year ended 30 September 2024 (As per BSE Announcement Dated on 06/11/2024) | ||
| Board Meeting | 23 Aug 2024 | 23 Aug 2024 |
| Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Resignation of Company Secretary & Compliance Officer | ||
| Board Meeting | 12 Aug 2024 | 5 Aug 2024 |
| RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Un-Audited Standalone Financial Results for the quarter ended June 30 2024 Approval of Un-audited Quarterly Financial Results for the quarter ended June 30, 2024 | ||
| Board Meeting | 24 May 2024 | 13 May 2024 |
| RAYMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve Audited Standalone Financial Results as per Regulation 33 of SEBI (LODR) Regulations 2015 for the quarter and year ended March 31 2024 Approval of Audited Standalone Financial Results for the quarter and year ended March 31, 2024 Outcome of Board Meeting Dated 24/05/2024 (As Per BSE Announcement Dated on 24/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
